Cerecin   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Singapore Singapore (2001)

Organization Overview

First Clinical Trial
2004
NCT00142805
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Accera, Inc. | Cerecin

Active Ingredients

Drugs in Phase 3 Trials (3)

caprylic/capric/succinic triglyceride (4 trials)

long-chain triglyceride (1 trial)

tricaprylyl glycerol (14 trials)

Drugs in Phase 2 Trials (1)

octanoic acid (2 trials)

Drugs in Phase 1 Trials (3)

caprylic acid (6 trials)

cow milk (1 trial)

medium chain triglyceride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alzheimer Disease (Phase 3)

Memory Disorders (Phase 2)

Migraine Disorders (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 21
  • # of Trial APIs: 7